Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
31,578
Total Claims
$2.4M
Drug Cost
1,430
Beneficiaries
$1,673
Cost/Patient
Risk Score Breakdown 29/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-84%
Opioid rate vs peers
0.4% vs 2.6% avg
+57%
Cost per patient vs peers
$1,673 vs $1,068 avg
+59%
Brand preference vs peers
14.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.4%
Opioid Rate
131
Opioid Claims
$6,005
Opioid Cost
20.6%
Long-Acting Rate
Brand vs Generic
Brand: 4,501 claims · $1.6M
Generic: 26,903 claims · $760K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 868 | $282K |
| Deutetrabenazine | 45 | $113K |
| Empagliflozin | 234 | $106K |
| Rivaroxaban | 243 | $80K |
| Dulaglutide | 81 | $73K |
| Cinacalcet Hcl | 28 | $61K |
| Apremilast | 45 | $55K |
| Rifaximin | 42 | $45K |
| Insulin Glargine,hum.Rec.Anlog | 109 | $36K |
| Linagliptin | 98 | $33K |
| Sitagliptin Phosphate | 97 | $31K |
| Fluticasone/Umeclidin/Vilanter | 45 | $29K |
| Atorvastatin Calcium | 1,963 | $28K |
| Budesonide/Formoterol Fumarate | 68 | $28K |
| Tiotropium Bromide | 69 | $28K |
Prescribing Profile
Patient Profile
77
Avg Age
63%
Female
2.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data